瑞可達(688800.SH):泰州工廠的選址是由於公司要擴充CCS產品的產業鏈產能
格隆匯8月7日丨瑞可達(688800.SH)近期在接待機構投資者調研時表示,公司目前主要有蘇州、四川2個生產基地,生產基地佈局主要是基於客户就近配套服務和輻射國內主要地區的原則。泰州工廠的選址是由於公司要擴充CCS產品的產業鏈產能,且泰州工廠因為已有部分配套的基礎設施,預計今年晚些時候即可開始部分投產,同時將無錫租賃工廠搬遷至泰州工廠進行資源有效整合。海外工廠的設立是基於客户全球化、供應鏈本地化的要求,同時承接海外新項目新車型的定點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.